World's Best Scientists 2026 revealed!
VIEW LIST
David R. Spigel

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 105 6632 6235 640 611 768 85540

David R. Spigel publications per year

The chart shows the history of publications by David R. Spigel between 2002 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. David R. Spigel published across 24 years, from 2002 to 2025, averaging 37.3 papers a year. Output peaked at 77 publications in 2023. 112 of the 895 publications appeared in the last two years.

No. of publications
25 50 75
Bar chart. Horizontal axis: year, 2002 to 2025. Vertical axis: number of publications, 0 to 77. Peak 77 publications in 2023. 2002: 3 publications 2003: 4 publications 2004: 16 publications 2005: 26 publications 2006: 26 publications 2007: 23 publications 2008: 25 publications 2009: 26 publications 2010: 29 publications 2011: 32 publications 2012: 42 publications 2013: 32 publications 2014: 35 publications 2015: 38 publications 2016: 64 publications 2017: 47 publications 2018: 46 publications 2019: 47 publications 2020: 37 publications 2021: 59 publications 2022: 49 publications 2023: 77 publications 2024: 54 publications 2025: 58 publications
2002 2025

895 publications in total across all disciplines

View publications per year as a table
David R. Spigel: publications per year, 2002 to 2025
Year Publications
2002 3
2003 4
2004 16
2005 26
2006 26
2007 23
2008 25
2009 26
2010 29
2011 32
2012 42
2013 32
2014 35
2015 38
2016 64
2017 47
2018 46
2019 47
2020 37
2021 59
2022 49
2023 77
2024 54
2025 58
Total 895
Download as CSV

David R. Spigel publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David R. Spigel sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 761–780 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 768 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228 768
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

David R. Spigel D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David R. Spigel sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 104–105 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 105 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513 105
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

David R. Spigel is affiliated with the Sarah Cannon Research Institute in the United Kingdom. Their research primarily focuses on medicine with a strong specialization in oncology. This expertise extends into subfields such as pulmonary and respiratory medicine, cancer research, molecular biology, and immunology.

Their work encompasses various topics, notably:

  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Treatments and Mutations
  • Cancer Genomics and Diagnostics
  • Colorectal Cancer Treatments and Studies
  • Lung Cancer Research Studies
  • Lung Cancer Diagnosis and Treatment
  • Peptidase Inhibition and Analysis

David R. Spigel has a history of collaboration with several frequent co-authors, including:

  • Luis Paz-Ares
  • Howard A. Burris
  • Alexander I. Spira
  • Byoung Chul Cho
  • Suzanne F. Jones

They have published extensively in various respected venues such as:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • Cancer Research
  • Journal of Thoracic Oncology
  • Regular and Young Investigator Award Abstracts

Among recent notable publications are:

  • "Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC," 2020, New England Journal of Medicine
  • "Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA," 2020, Annals of Oncology
  • "Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial," 2020, The Lancet Oncology
  • "Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer," 2021, Journal of Clinical Oncology
  • "Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial," 2021, Journal of Thoracic Oncology

Best Publications

  • Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

    Suzanne L. Topalian;F. Stephen Hodi;Julie R. Brahmer;Scott N. Gettinger

  • Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

    H. Borghaei;L. Paz-Ares;L. Horn;D. R. Spigel

  • Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer

    Julie Brahmer;Karen L Reckamp;Paul Baas;Lucio Crinò

  • Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

    Scott J. Antonia;Augusto Villegas;Davey Daniel;David Vicente

  • Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

    Luis Paz-Ares;Mikhail Dvorkin;Yuanbin Chen;Niels Reinmuth

  • STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

    Ferdinandos Skoulidis;Michael E. Goldberg;Danielle M. Greenawalt;Matthew D. Hellmann

  • Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

    Scott N. Gettinger;Leora Horn;Leena Gandhi;David R. Spigel

  • A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer

    J. Randolph Hecht;Edith Mitchell;Tarek Chidiac;Carroll Scroggin

  • Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC

    Roy S Herbst;Giuseppe Giaccone;Filippo de Marinis;Niels Reinmuth

  • First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring Somatic EGFR Mutations

    Lecia V. Sequist;Renato G. Martins;David Spigel;Steven M. Grunberg

  • Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

    M C Liu;G R Oxnard;E A Klein;C Swanton

  • Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).

    Leora Horn;David R. Spigel;Everett E. Vokes;Esther Holgado

  • Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: Results From the CA209-003 Study

    Scott Gettinger;Leora Horn;David Jackman;David Spigel

  • Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial

    Alice T Shaw;Tae Min Kim;Lucio Crinò;Cesare Gridelli

  • First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers.

    Neal Ready;Matthew D. Hellmann;Mark M. Awad;Gregory A. Otterson

  • Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

    David R. Spigel;Thomas J. Ervin;Rodryg A. Ramlau;Davey B. Daniel

  • Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study

    Charles M Rudin;M Catherine Pietanza;Todd M Bauer;Neal Ready

  • Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer.

    Martin Reck;Alexander Luft;Aleksandra Szczesna;Libor Havel

  • Five-Year Survival and Correlates among Patients with Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated with Nivolumab

    Suzanne L. Topalian;F. Stephen Hodi;Julie R. Brahmer;Scott N. Gettinger

  • Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.

    Jonathan W Goldman;Mikhail Dvorkin;Yuanbin Chen;Niels Reinmuth

Frequent Co-Authors

John D. Hainsworth
John D. Hainsworth Sarah Cannon Research Institute
Howard A. Burris
Howard A. Burris Sarah Cannon Research Institute
F. Anthony Greco
F. Anthony Greco Sarah Cannon Research Institute
Luis Paz-Ares
Luis Paz-Ares Complutense University of Madrid
Leora Horn
Leora Horn Vanderbilt University Medical Center
Scott N. Gettinger
Scott N. Gettinger Yale University
Julie R. Brahmer
Julie R. Brahmer Johns Hopkins University
Fabrice Barlesi
Fabrice Barlesi Institut Gustave Roussy
Mark A. Socinski
Mark A. Socinski University of North Carolina at Chapel Hill
Scott J. Antonia
Scott J. Antonia Duke University

External Links

Personal website of David R. Spigel

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn't always mean following the traditional pathway. There are diverse cheapest bsn programs online available, allowing students to earn a respected nursing degree while managing costs and maintaining flexibility. These programs are tailored for students who want an affordable and accessible way to enter the nursing profession.

For registered nurses seeking advanced education, the average cost of rn to bsn programs is another crucial factor to consider. Many online RN to BSN programs are competitively priced and designed to fit a working nurse’s schedule.

Professionals looking to make a significant impact in academia or healthcare leadership may consider pursuing phd nursing programs. These online options provide advanced research skills and open doors to teaching and leadership roles.

Additionally, those without a nursing background can find direct entry nurse practitioner programs for non-nurses online—a fast-track route to becoming a nurse practitioner for those who hold a non-nursing bachelor’s degree. These online degrees support varied career goals within health care, providing flexible and affordable options for aspiring professionals.

Best Scientists Citing David R. Spigel

Benjamin Besse

Benjamin Besse

University of Paris-Saclay

Publications: 134

Jedd D. Wolchok

Jedd D. Wolchok

Cornell University

Publications: 106

F. Stephen Hodi

F. Stephen Hodi

Harvard University

Publications: 92

Rafael Rosell

Rafael Rosell

Autonomous University of Barcelona

Publications: 81

Matthew D. Hellmann

Matthew D. Hellmann

Memorial Sloan Kettering Cancer Center

Publications: 81

Martin Reck

Martin Reck

LungenClinic Grosshansdorf

Publications: 79

Michael A. Postow

Michael A. Postow

Memorial Sloan Kettering Cancer Center

Publications: 76

John V. Heymach

John V. Heymach

The University of Texas MD Anderson Cancer Center

Publications: 74

Ignacio I. Wistuba

Ignacio I. Wistuba

The University of Texas MD Anderson Cancer Center

Publications: 73

Yi-Long Wu

Yi-Long Wu

Guangdong Provincial People’s Hospital

Publications: 71

Myung-Ju Ahn

Myung-Ju Ahn

Sungkyunkwan University

Publications: 70

Pasi A. Jänne

Pasi A. Jänne

Harvard University

Publications: 69

Kazuhiko Nakagawa

Kazuhiko Nakagawa

Kindai University

Publications: 68

Julie R. Brahmer

Julie R. Brahmer

Johns Hopkins University

Publications: 67

Aurélien Marabelle

Aurélien Marabelle

Institut Gustave Roussy

Publications: 67

Caicun Zhou

Caicun Zhou

Tongji University

Publications: 67

Trending Scientists

Marc Desquesnes

Marc Desquesnes

University of Montpellier

David M. Buss

David M. Buss

The University of Texas at Austin

Marc Sauvage

Marc Sauvage

University of Paris-Saclay

Kwok-Yung Yuen

Kwok-Yung Yuen

University of Hong Kong

Neal Butchart

Neal Butchart

Met Office

Wolfgang Steinbrecht

Wolfgang Steinbrecht

German Meteorological Service

Simon Yueh

Simon Yueh

Jet Propulsion Lab

Adaikalavan Ramasamy

Adaikalavan Ramasamy

A*STAR - Agency for Science, Technology and Research

Jeffery D. Molkentin

Jeffery D. Molkentin

Cincinnati Children's Hospital Medical Center

Cecilia Cheng-Mayer

Cecilia Cheng-Mayer

Aaron Diamond AIDS Research Center

Mariolina Salio

Mariolina Salio

University of Oxford

Daneel Ferreira

Daneel Ferreira

University of Mississippi

Richard G. Ball

Richard G. Ball

MSD (United States)

Marie-Aline Charles

Marie-Aline Charles

Inserm

Jana A. Eccard

Jana A. Eccard

University of Potsdam

John R. Squires

John R. Squires

US Forest Service

Related Medicine Rankings & Guides

2027 Most Affordable Master’s in Health Science Degrees

2027 Most Affordable Master’s in Health Science Degrees
2027 Most Affordable Online LVN Programs

2027 Most Affordable Online LVN Programs
2027 Best Nursing Schools in Minnesota – Accredited ADN, BSN, MSN Programs

2027 Best Nursing Schools in Minnesota – Accredited ADN, BSN, MSN Programs
September 2027 Best Online Doctorate in Pharmacy (PharmD.) Programs

September 2027 Best Online Doctorate in Pharmacy (PharmD.) Programs
2027 Best Nurse Practitioner Programs in Oklahoma – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Oklahoma – Accredited Schools Online & Campus
2027 Best Online Respiratory Therapy Programs

2027 Best Online Respiratory Therapy Programs
September 2027 Best Online Kinesiology Programs

September 2027 Best Online Kinesiology Programs
2027 Fastest Online MSN in Psychiatric Mental Health NP Programs

2027 Fastest Online MSN in Psychiatric Mental Health NP Programs
September 2027 Best Online Certificate Programs in Medical Billing & Coding Programs

September 2027 Best Online Certificate Programs in Medical Billing & Coding Programs
September 2027 Best Online Master’s of Science in Nursing Degree Programs

September 2027 Best Online Master’s of Science in Nursing Degree Programs
2027 Easiest MPH Online Programs to Get Into

2027 Easiest MPH Online Programs to Get Into
2027 Best Paramedic-to-RN Bridge Programs

2027 Best Paramedic-to-RN Bridge Programs
2027 Best Online Master of Health Administration (MHA) Programs

2027 Best Online Master of Health Administration (MHA) Programs
2027 Most Affordable Online Medical Billing and Coding Courses

2027 Most Affordable Online Medical Billing and Coding Courses
2027 Best Nurse Practitioner Programs in Mississippi – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Mississippi – Accredited Schools Online & Campus
2027 Most Affordable Online Associate’s Degree in Radiology

2027 Most Affordable Online Associate’s Degree in Radiology
2027 Most Affordable Online Medical Assistant Programs

2027 Most Affordable Online Medical Assistant Programs
2027 Most Affordable Online Accelerated Nursing Programs With High Graduation Rate

2027 Most Affordable Online Accelerated Nursing Programs With High Graduation Rate
2027 Best Pathways to Pursue MSN without a BSN Degree

2027 Best Pathways to Pursue MSN without a BSN Degree
2027 Fastest Online MSN in Health/Nursing Informatics Programs

2027 Fastest Online MSN in Health/Nursing Informatics Programs
September 2027 Fast Track LPN Programs Online - 6, 9, 10, 11, 12 Month Programs

September 2027 Fast Track LPN Programs Online - 6, 9, 10, 11, 12 Month Programs

Recently Published Articles

2027 Most Affordable Online MBA in Information Technology Degree Programs

2027 Most Affordable Online MBA in Information Technology Degree Programs
2027 Online Analytics Bachelor's Degree Programs With Weekly Start Dates

2027 Online Analytics Bachelor's Degree Programs With Weekly Start Dates
2027 Cheapest and Shortest Online Educational Leadership Degree Programs That Pay Well: Cost, Duration, and Salary Outlook

2027 Cheapest and Shortest Online Educational Leadership Degree Programs That Pay Well: Cost, Duration, and Salary Outlook
2027 Shortest Online Communication Disorders Bachelor's Degree Programs That Pay Well: Cost, Time to Completion, and Salary Outlook

2027 Shortest Online Communication Disorders Bachelor's Degree Programs That Pay Well: Cost, Time to Completion, and Salary Outlook
2027 Cheapest Way to Get a Teaching Credential in Missouri: Requirements & Certification

2027 Cheapest Way to Get a Teaching Credential in Missouri: Requirements & Certification
2027 Best Marriage and Family Therapy (MFT) Programs in Alabama: Online & Campus

2027 Best Marriage and Family Therapy (MFT) Programs in Alabama: Online & Campus
2027 Video Game Design Degree Guide: Costs, Requirements & Job Opportunities

2027 Video Game Design Degree Guide: Costs, Requirements & Job Opportunities
2027 Different Types of Sociology Master's Degrees: Specializations, Careers, and Salaries

2027 Different Types of Sociology Master's Degrees: Specializations, Careers, and Salaries
2027 Secondary Teaching Certification: Requirements, Career Paths, Salaries

2027 Secondary Teaching Certification: Requirements, Career Paths, Salaries
2027 Best Medical Assistant Schools & Programs in Utah – How to Become a Medical Assistant in Utah

2027 Best Medical Assistant Schools & Programs in Utah – How to Become a Medical Assistant in Utah
2027 Is Surgical Tech a Hard Major? What Students Should Know

2027 Is Surgical Tech a Hard Major? What Students Should Know
2027 AI, Automation, and the Future of Game Development Degree Careers

2027 AI, Automation, and the Future of Game Development Degree Careers
2027 Data Analytics Programs With Placement Support for Practicum or Clinicals

2027 Data Analytics Programs With Placement Support for Practicum or Clinicals
2027 What is an LPC? Degrees, Careers & Salary

2027 What is an LPC? Degrees, Careers & Salary
2027 Best Online Counselor Education Degree Programs

2027 Best Online Counselor Education Degree Programs
2027 Most In-Demand Special Education Master's Specializations

2027 Most In-Demand Special Education Master's Specializations
2027 How to Become a High School Math Teacher in Oregon

2027 How to Become a High School Math Teacher in Oregon
2027 Which Schools Offer Flexible Start-Anytime Enrollment for a Finance Degree Master's Program?

2027 Which Schools Offer Flexible Start-Anytime Enrollment for a Finance Degree Master's Program?
2027 Associate to Bachelor's in Electrical Engineering: Transfer Pathways Explained

2027 Associate to Bachelor's in Electrical Engineering: Transfer Pathways Explained
2027 Best Value Online Art History Master's Degrees: Affordable Accredited Programs with the Highest ROI

2027 Best Value Online Art History Master's Degrees: Affordable Accredited Programs with the Highest ROI
2027 Purdue Global Online AASBA in Information Processing: Cost, Curriculum, Admissions, and Career Outcomes

2027 Purdue Global Online AASBA in Information Processing: Cost, Curriculum, Admissions, and Career Outcomes